The iStent inject was safe and effective for treating multiple types of primary open-angle glaucoma individually and in conjunction with cataract surgery, according to data published in Journal of Cataract and Refractive Surgery.
Cataract surgery lowers IOP, medication use
Patients with ocular hypertension may benefit from cataract surgery, according to findings published in the American Journal of Ophthalmology.“Studies suggest that cataract surgery lowers IOP, and that this reduction is generally proportional to presurgical IOP. As well, several papers report a decrease in ocular hypotensive medications with cataract surgery,” Steven L. Mansberger, MD, MPH, ophthalmologist at Legacy Health in Portland, …
Dry eye disease cream demonstrates improvement, rapid onset of action in phase 2 trial
AXR-270 demonstrated ‘statically and clinically meaningful improvement’ in patients with dry eye disease associated with meibomian gland dysfunction, according to a press release from AxeroVision.
Visus Therapeutics to Host Its First Capital Markets Day Tomorrow
Visus Therapeutics will host its first Capital Markets Day for investors, analysts, and media tomorrow, August 31, 2021, from 10 am to 2 pm ET at Convene, 530 Fifth Avenue at 45th Street in New York City. During the Capital Markets Day, Ben Bergo, co-founder and chief executive officer; Rhett Schiffman, MD, MS, MHSA, co-founder, chief medical officer and head of …
Complexity Gaming Kicks Off Year-Long Partnership With Alcon
Esports company Complexity Gaming announced a partnership with Alcon. The partnership will designate Alcon’s signature brand of lubricant eye drops, Systane, as the first official eye care partner of Complexity Gaming.
Bausch Health Converts $10 Million Option Payment to Allegro into Equity Interest
Bausch Health has exercised its option to convert a $10 million upfront payment to Allegro Ophthalmics into a minor equity interest in Allegro, under the terms of an agreement announced in September 2020.
Nova Eye Medical Acquires Glaucoma Treatment Patents from Dallas Company
Australian company Nova Eye Medical announced Aug. 26 that it had completed an acquisition of a patent portfolio related to ab interno trabeculotomy from Innovative Glaucoma Solutions, a surgeon-owned company in Dallas. Nova Eye, which maintains a US base in Fremont, California, paid US $2 million up front and 1.7 million in Nova Eye shares for the acquisition. Tom Spurling, managing director …
Artificial intelligence may accurately identify glaucoma medication bottles
Artificial intelligence has demonstrated the ability to differentiate bottles of ophthalmic medications and could feasibly function on a smartphone platform, according to a study published in Ophthalmology Glaucoma. Researchers pretrained seven convolutional neural network (CNN) models to classify five common ophthalmic medications using a set of 2,250 images captured by mobile phones. The two top-performing networks were included in separate iOS …
Topcon Healthcare, RetInSight to Partner on AI Technology
Topcon Healthcare reported Aug. 3 that it would integrate the retina AI technology of RetInSight GmbH, of Austria, into its OCT devices and Harmony cloud-based data management technology under a new partnership. Financial details were not disclosed. The Oakland, New Jersey, company, part of Tokyo-based Topcon Corporation, said the move was designed to lead to improved clinical decision making and …
Eyecelerator Innovation Forum Draws More than 500 Attendees
Industry, clinicians, and entrepreneurs who walked into Eyecelerator’s first in-person meeting were elated to be face to face, with jokes flying about Zoom dress codes and the lack of barking dogs during conversations. The business forum took place July 22 in conjunction with the 2021 meeting of the American Society of Cataract and Refractive Surgery at the Mandalay Bay Convention …
